KRYS
Price
$212.02
Change
+$7.79 (+3.81%)
Updated
Nov 21 closing price
Capitalization
6.15B
100 days until earnings call
Intraday BUY SELL Signals
RXRX
Price
$4.17
Change
+$0.32 (+8.31%)
Updated
Nov 21 closing price
Capitalization
2.17B
102 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KRYS vs RXRX

Header iconKRYS vs RXRX Comparison
Open Charts KRYS vs RXRXBanner chart's image
Krystal Biotech
Price$212.02
Change+$7.79 (+3.81%)
Volume$330.97K
Capitalization6.15B
Recursion Pharmaceuticals
Price$4.17
Change+$0.32 (+8.31%)
Volume$33.63M
Capitalization2.17B
KRYS vs RXRX Comparison Chart in %
KRYS
Daily Signal:
Gain/Loss:
RXRX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
KRYS vs. RXRX commentary
Nov 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRYS is a Hold and RXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 22, 2025
Stock price -- (KRYS: $212.03 vs. RXRX: $4.17)
Brand notoriety: KRYS and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRYS: 101% vs. RXRX: 66%
Market capitalization -- KRYS: $6.15B vs. RXRX: $2.17B
KRYS [@Biotechnology] is valued at $6.15B. RXRX’s [@Biotechnology] market capitalization is $2.17B. The market cap for tickers in the [@Biotechnology] industry ranges from $108.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRYS’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • KRYS’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, KRYS is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRYS’s TA Score shows that 3 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • KRYS’s TA Score: 3 bullish, 5 bearish.
  • RXRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both KRYS and RXRX are a bad buy in the short-term.

Price Growth

KRYS (@Biotechnology) experienced а +2.85% price change this week, while RXRX (@Biotechnology) price change was +0.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -3.31%, and the average quarterly price growth was +62.87%.

Reported Earning Dates

KRYS is expected to report earnings on Mar 02, 2026.

RXRX is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($6.15B) has a higher market cap than RXRX($2.17B). KRYS YTD gains are higher at: 35.344 vs. RXRX (-38.314). KRYS has higher annual earnings (EBITDA): 158M vs. RXRX (-583.64M). KRYS has more cash in the bank: 682M vs. RXRX (525M). KRYS has less debt than RXRX: KRYS (9.68M) vs RXRX (88.1M). KRYS has higher revenues than RXRX: KRYS (359M) vs RXRX (64.5M).
KRYSRXRXKRYS / RXRX
Capitalization6.15B2.17B283%
EBITDA158M-583.64M-27%
Gain YTD35.344-38.314-92%
P/E Ratio31.79N/A-
Revenue359M64.5M557%
Total Cash682M525M130%
Total Debt9.68M88.1M11%
FUNDAMENTALS RATINGS
KRYS: Fundamental Ratings
KRYS
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
25
SMR RATING
1..100
51
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KRYSRXRX
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 27 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
KRYS
Daily Signal:
Gain/Loss:
RXRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JCSCX21.500.53
+2.53%
Janus Henderson Small Cap Value C
CIMCX27.190.21
+0.78%
American Funds Income Fund of Amer 529C
MCISX18.76N/A
N/A
Victory Trivalent International Sm-Cp C
KMDVX30.54N/A
N/A
Keeley Gabelli Mid Cap Dividend A
VVSGX16.51N/A
N/A
VALIC Company I Small Cap Growth